Nanoparticle characterization for cancer nanotechnology and other biological applications
- PMID: 20217588
- DOI: 10.1007/978-1-60761-609-2_4
Nanoparticle characterization for cancer nanotechnology and other biological applications
Abstract
Nanotechnology is actively being used to develop promising diagnostics and therapeutics tools for the treatment of cancer and many other diseases. The unique properties of nanomaterials offer an exciting frontier of possibilities for biomedical researchers and scientists. Because existing knowledge of macroscopic materials does not always allow for adequate prediction of the characteristics and behaviors of nanoscale materials in controlled environments, much less in biological systems, careful nanoparticle characterization should accompany biomedical applications of these materials. Informed correlations between adequately characterized nanomaterial properties and reliable biological endpoints are essential for guiding present and future researchers toward clinical nanotechnology-based solutions for cancer. Biological environments are notoriously dynamic; hence, nanoparticulate interactions within these environments will likely be comparatively diverse. For this reason, we recommend that an interactive and systematic approach to material characterization be taken when attempting to elucidate or measure biological interactions with nanoscale materials. We intend for this chapter to be a practical guide that could be used by researchers to identify key nanomaterial characteristics that require measurement for their systems and the appropriate techniques to perform those measurements. Each section includes a basic overview of each measurement and notes on how to address some of the common difficulties associated with nanomaterial characterization.
Similar articles
-
Research strategies for safety evaluation of nanomaterials. Part VI. Characterization of nanoscale particles for toxicological evaluation.Toxicol Sci. 2006 Apr;90(2):296-303. doi: 10.1093/toxsci/kfj099. Epub 2006 Jan 11. Toxicol Sci. 2006. PMID: 16407094
-
Composite nanoparticles take aim at cancer.ACS Nano. 2008 Nov 25;2(11):2200-5. doi: 10.1021/nn800716j. ACS Nano. 2008. PMID: 19206383 Review.
-
A perspective on bioconjugated nanoparticles and quantum dots.Colloids Surf B Biointerfaces. 2007 Sep 1;59(1):1-10. doi: 10.1016/j.colsurfb.2007.04.019. Epub 2007 May 3. Colloids Surf B Biointerfaces. 2007. PMID: 17544637 Review.
-
Effect of surface properties on nanoparticle-cell interactions.Small. 2010 Jan;6(1):12-21. doi: 10.1002/smll.200901158. Small. 2010. PMID: 19844908 Review.
-
Unique benefits of nanotechnology to drug delivery and diagnostics.Methods Mol Biol. 2011;697:3-8. doi: 10.1007/978-1-60327-198-1_1. Methods Mol Biol. 2011. PMID: 21116949
Cited by
-
Laser Ablation for Cancer: Past, Present and Future.J Funct Biomater. 2017 Jun 14;8(2):19. doi: 10.3390/jfb8020019. J Funct Biomater. 2017. PMID: 28613248 Free PMC article. Review.
-
Preparation, characterization, and in vitro dosimetry of dispersed, engineered nanomaterials.Nat Protoc. 2017 Feb;12(2):355-371. doi: 10.1038/nprot.2016.172. Epub 2017 Jan 19. Nat Protoc. 2017. PMID: 28102836 Free PMC article.
-
Toward advancing nano-object count metrology: a best practice framework.Environ Health Perspect. 2013 Nov-Dec;121(11-12):1282-91. doi: 10.1289/ehp.1306957. Epub 2013 Sep 27. Environ Health Perspect. 2013. PMID: 24076973 Free PMC article. Review.
-
How the Lack of Chitosan Characterization Precludes Implementation of the Safe-by-Design Concept.Front Bioeng Biotechnol. 2020 Mar 10;8:165. doi: 10.3389/fbioe.2020.00165. eCollection 2020. Front Bioeng Biotechnol. 2020. PMID: 32211394 Free PMC article. Review.
-
Nickel-doped cerium oxide nanoparticles: biosynthesis, cytotoxicity and UV protection studies.RSC Adv. 2020 Jan 23;10(7):3967-3977. doi: 10.1039/c9ra09076b. eCollection 2020 Jan 22. RSC Adv. 2020. PMID: 35492632 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources